Felipe Soares

Felipe Soares

Auto-generated profile, based on publicly available information

Felipe Soares

Computer Science Department, The University of Sheffield, Western Bank, Sheffield S10 2TN, UK

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2021 in Computer Methods and Programs in Biomedicine
Verified
Journal Article
Closed access
Federico CabitzaFederico Cabitza
Federico Cabitza
ACAndrea Campagner
Andrea Campagner
FSFelipe Soares
Felipe Soares
LGLuis García de Guadiana-Romualdo
Luis García de Guadiana-Romualdo
FWFeyissa Challa Waka
Feyissa Challa Waka
ACAnna Carobene
Anna Carobene

12 July 2022 in BMJ
Verified
Journal Article
Open access
PDF file
VJValentijn de Jong
Valentijn de Jong
RRRebecca Z Rousset
Rebecca Z Rousset
NANeftali Eduardo Antonio-Villa
Neftali Eduardo Antonio-Villa
ABArnoldus G Buenen
Arnoldus G Buenen
BCBen Van Calster
Ben Van Calster
TDThomas P. Debray
Thomas P. Debray
Objective: To externally validate various prognostic models and scoring rules for predicting short term mortality in patients admitted to hospital for covid-19. Design: Two stage individual participant data meta-analysis. Setting: Secondary and tertiary care. Participants: 46 914 patients across 18 countries, admitted to a hospital with polymerase chain reaction confirmed covid-19 from November 2019 to April 2021. Data sources: Multiple (clustered) cohorts in Brazil, Belgium, China, Czech Republic, Egypt, France, Iran, Israel, Italy, Mexico, Netherlands, Portugal, Russia, Saudi Arabia, Spain, Sweden, United Kingdom, and United States previously identified by a living systematic review of covid-19 prediction models published in The BMJ , and through PROSPERO, reference checking, and expert knowledge. Model selection and eligibility criteria: Prognostic models identified by the living systematic review and through contacting experts. A priori models were excluded that had a high risk of bias in the participant domain of PROBAST (prediction model study risk of bias assessment tool) or for which the applicability was deemed poor. Methods: Eight prognostic models with diverse predictors were identified and validated. A two stage individual participant data meta-analysis was performed of the estimated model concordance (C) statistic, calibration slope, calibration-in-the-large, and observed to expected ratio (O:E) across the included clusters. Main outcome measures: 30 day mortality or in-hospital mortality. Results: Datasets included 27 clusters from 18 different countries and contained data on 46 914patients. The pooled estimates ranged from 0.67 to 0.80 (C statistic), 0.22 to 1.22 (calibration slope), and 0.18 to 2.59 (O:E ratio) and were prone to substantial between study heterogeneity. The 4C Mortality Score by Knight et al (pooled C statistic 0.80, 95% confidence interval 0.75 to 0.84, 95% prediction interval 0.72 to 0.86) and clinical model by Wang et al (0.77, 0.73 to 0.80, 0.63 to 0.87) had the highest discriminative ability. On average, 29% fewer deaths were observed than predicted by the 4C Mortality Score (pooled O:E 0.71, 95% confidence interval 0.45 to 1.11, 95% prediction interval 0.21 to 2.39), 35% fewer than predicted by the Wang clinical model (0.65, 0.52 to 0.82, 0.23 to 1.89), and 4% fewer than predicted by Xie et al’s model (0.96, 0.59 to 1.55, 0.21 to 4.28). Conclusion: The prognostic value of the included models varied greatly between the data sources. Although the Knight 4C Mortality Score and Wang clinical model appeared most promising, recalibration (intercept and slope updates) is needed before implementation in routine care.

14 April 2020 in medRxiv
Verified
Preprint
Open access
PDF file
FSFelipe Soares
Felipe Soares
AVAline Villavicencio
Aline Villavicencio
MAMichel Jose Anzanello
Michel Jose Anzanello
FFFlavio Sanson Fogliatto
Flavio Sanson Fogliatto
MIMarco Idiart
Marco Idiart
Mark StevensonMark Stevenson
Mark Stevenson
Background: The SARS-CoV-2 virus responsible for COVID-19 poses a significant challenge to healthcare systems worldwide. Despite governmental initiatives aimed at containing the spread of the disease, several countries are experiencing unmanageable increases in the demand for ICU beds, medical equipment, and larger testing capacity. Efficient COVID-19 diagnosis enables healthcare systems to provide better care for patients while protecting caregivers from the disease. However, many countries are constrained by the limited amount of test kits available, lack of equipment and trained professionals. In the case of patients visiting emergency rooms (ERs) with a suspect of COVID-19, prompt diagnosis may improve the outcome and even provide information for efficient hospital management. In such a context, a quick, inexpensive and readily available test to perform an initial triage in ERs could help to smooth patient flow, provide better patient care, and reduce the backlog of exams. Methods: In this Case-control quantitative study, we developed a strategy backed by artificial intelligence to perform an initial screening of suspect COVID-19 patients. We developed a machine learning classifier that takes widely available simple blood exams as input and classifies samples as likely to be positive (having SARS-CoV-2) or negative (not having SARS-CoV-2). Based on this initial classification, positive cases can be referred for further highly sensitive testing (e.g. CT scan, or specific antibodies). We used publicly available data from the Albert Einstein Hospital in Brazil from 5,644 patients. Focusing on simple blood exam figures as main predictors, a sample of 599 subjects that had the fewest missing values for 16 common exams were selected. From these 599 patients, 81 tested positive for SARS-CoV-2 (determined by RT-PCR). Based on the reduced dataset, we built an artificial intelligence classification framework, ER-CoV, aiming at determining if suspect patients arriving in ER were likely to be negative for SARS-CoV-2, that is, to predict if that suspect patient is negative for COVID-19. The primary goal of this investigation is to develop a classifier with high specificity and high negative predictive values, with reasonable sensitivity. Findings: We identified that our AI framework achieved an average specificity of 85.98% [95%CI: 84.94 – 86.84] and negative predictive value (NPV) of 94.92% [95%CI: 94.37% – 95.37%]. Those values are completely aligned with our goal of providing an effective low-cost system to triage suspect patients in ERs. As for sensitivity, our model achieved an average of 70.25% [95%CI: 66.57% – 73.12%] and positive predictive value (PPV) of 44.96% [95%CI: 43.15% – 46.87%]. The area under the curve (AUC) of the receiver operating characteristic (ROC) was 86.78% [95%CI: 85.65% – 87.90%]. An error analysis (inspection of which patients were misclassified) identified that, on average, 28% of the false negative results would have been hospitalized anyway; thus the model is making mistakes for severe cases that would not be overlooked, partially mitigating the fact that the test is not highly sensitive. All code for our AI model, called ER-CoV is publicly available at https://github.com/soares-f/ER-CoV . Interpretation: Based on the capacity of our model to accurately predict which cases are negative from suspect patients arriving in emergency rooms, we envision that this framework may play an important role in patient triage. Probably the most important outcome is related to testing availability, which at this point is extremely low in many countries. Considering the achieved specificity, we could reduce by at least 90% the number of SARS-CoV-2 tests performed in emergency rooms, with around 5% chance of getting a false negative. The second important outcome is related to patient management in hospitals. Patients predicted as positive by our framework could be immediately separated from other patients while waiting for the results of confirmatory tests. This could reduce the spread rate within hospitals since in many of them all suspect cases are kept in the same ward. In Brazil, where the data was collected, rate infection is starting to quickly spread and the lead time of a SARS-CoV-2 may be up to 2 weeks.

1 January 2018 in Chemometrics and Intelligent Laboratory Systems
Verified
Journal Article
Closed access
FSFelipe Soares
Felipe Soares
MAMichel J. Anzanello
Michel J. Anzanello

1 January 2019 in Cancer Control
Verified
Journal Article
Open access
PDF file
FFFlavio Sanson Fogliatto
Flavio Sanson Fogliatto
MAMichel J. Anzanello
Michel J. Anzanello
FSFelipe Soares
Felipe Soares
PBPriscila G. Brust-Renck
Priscila G. Brust-Renck
Several statistical-based approaches have been developed to support medical personnel in early breast cancer detection. This article presents a method for feature selection aimed at classifying cases into categories based on patients’ breast tissue measures and protein microarray. The effectiveness of this feature selection strategy was evaluated against the commonly used Wisconsin Breast Cancer Database—WBCD (with several patients and fewer features) and a new protein microarray data set (with several features and fewer patients). Features were ranked according to a feature importance index that combines parameters emerging from the unsupervised method of principal component analysis and the supervised method of Bhattacharyya distance. Observations of a training set were iteratively categorized into malignant and benign cases through 3 classification techniques: k-Nearest Neighbor, linear discriminant analysis, and probabilistic neural network. After each classification, the feature with the smallest importance index was removed, and a new categorization was carried out until there was only one feature left. The subset yielding maximum accuracy was used to classify observations in the testing set. Our method yielded average 99.17% accurate classifications in the testing set while retaining average 4.61 out of 9 features in the WBCD, which is comparable to the best results reported by the literature on that data set, with the advantage of relying on simple and widely available multivariate techniques. When applied to the microarray data, the method yielded average accuracy of 98.30% while retaining average 2.17% of the original features. Our results can aid health-care professionals during early diagnosis of breast cancer.

1 July 2018 in Computers and Electronics in Agriculture
Verified
Journal Article
Closed access
FSFelipe Soares
Felipe Soares
MAMichel J. Anzanello
Michel J. Anzanello
FFFlavio Sanson Fogliatto
Flavio Sanson Fogliatto
MMMarcelo C.A. Marcelo
Marcelo C.A. Marcelo
MFMarco F. Ferrão
Marco F. Ferrão
DPDirce Pozebon
Dirce Pozebon